LamiSpine is the unique procedure designed by Unique Access Medical (UAM)
– global leader in innovative spinal cord treatments aimed at recovery.
It includes “laminectomy,” which is the removal of a small section of an SCI patient’s spine called a ”Lamina”, followed by “intra-spinal cord” injections of patented hAFSC Cytotherapy.
The laminectomy targets the precise location of spinal cord tissue damage using the AFSCs and delivers the maximum number of impact right at the injured location
LamiSpine surgery is suitable for complete or incomplete spinal injury. Especially patients with injuries at T11-L1 will benefit the most. Results are measured by bodily functions regained and symptoms reduced.
Cytotherapy using hAFSCs or MSCs are increasingly popular. This is partly due to the absence of side effects, but also due to the high success rates. For SCI, it is most effective when injected as direct and as local as possible, which is the case with LamiSpine.
Laminectomy plus intra-spinal hAFSC injections allow for direct targeting of the injured spinal tissue, so people suffering the symptoms of SCI can experience improvements in motor and sensory function. You could be next to feel empowered by LamiSpine surgery!
Kelly Longo, a 44-year-old patient from California, USA, was left with a T12 Spinal Cord Injury after she fell from climbing up the ladder to a rooftop.
Tudor is a 26-year-old man from Romania whose life came to an abrupt twist when he got into a car crash and, as a result, sustained a T12-L1 Spinal Cord Injury.
Luis Nunez got into a tragic car accident that left him with a C4 Spinal Cord Injury, after which, living a complete independent life was out of the question.
At the age of 24, Ephram Gudgeon’s life came to a dramatic twist when he got into a diving accident while swimming with his family back home in New Zealand.
20-year-old Jesse Apiti from New Zealand was diagnosed with complete Paraplegia after a workplace accident.
Copyright © 2019 | Unique Access Medical Pte Ltd
